Serveur d'exploration H2N2

Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.

Influenza vaccination in HBsAg positive chronic active hepatitis patients treated with interferon

Identifieur interne : 002848 ( Main/Exploration ); précédent : 002847; suivant : 002849

Influenza vaccination in HBsAg positive chronic active hepatitis patients treated with interferon

Auteurs : R. A. Heijtink [Pays-Bas] ; N. Masurel [Pays-Bas] ; W. Weimar [Pays-Bas] ; S. W. Schalm [Pays-Bas]

Source :

RBID : ISTEX:B99FB5277EB7FD3526C589F030844890AD4FA601

English descriptors

Abstract

Abstract: Sixteen patients with hepatitis B antigen (HBsAg) positive chronic active hepatitis (CAH) were vaccinated with the nonhuman influenza A virus Heq1Neq1; eight patients were also treated with leucocyte interferon. Prevaccination sera were negative for specific antibody in hemagglutination inhibition tests. Four weeks after vaccination all patients had responded with a homologous antibody titer. Between the interferon-treated and the untreated groups the differences in antibody titers against the vaccine virus were not significant. Concomitant with the antibody response against the nonhuman influenza virus, a fourfold or higher antibody rise was observed against the influenza A virus strains Hsw1N1 (in six treated and seven untreated patients), H1N1 (in six treated and four untreated patients) and H3N2 (in five treated patients only). The results suggest that a normal specific antibody response in HBsAg positive chronic active hepatitis patients is not significantly altered by leucocyte interferon, and that non-specific antibody production can occur in the absence of a serologic relationship.

Url:
DOI: 10.1007/BF02123710


Affiliations:


Links toward previous steps (curation, corpus...)


Le document en format XML

<record>
<TEI wicri:istexFullTextTei="biblStruct">
<teiHeader>
<fileDesc>
<titleStmt>
<title xml:lang="en">Influenza vaccination in HBsAg positive chronic active hepatitis patients treated with interferon</title>
<author>
<name sortKey="Heijtink, R A" sort="Heijtink, R A" uniqKey="Heijtink R" first="R. A." last="Heijtink">R. A. Heijtink</name>
</author>
<author>
<name sortKey="Masurel, N" sort="Masurel, N" uniqKey="Masurel N" first="N." last="Masurel">N. Masurel</name>
</author>
<author>
<name sortKey="Weimar, W" sort="Weimar, W" uniqKey="Weimar W" first="W." last="Weimar">W. Weimar</name>
</author>
<author>
<name sortKey="Schalm, S W" sort="Schalm, S W" uniqKey="Schalm S" first="S. W." last="Schalm">S. W. Schalm</name>
</author>
</titleStmt>
<publicationStmt>
<idno type="wicri:source">ISTEX</idno>
<idno type="RBID">ISTEX:B99FB5277EB7FD3526C589F030844890AD4FA601</idno>
<date when="1980" year="1980">1980</date>
<idno type="doi">10.1007/BF02123710</idno>
<idno type="url">https://api.istex.fr/ark:/67375/1BB-HK3H60L0-S/fulltext.pdf</idno>
<idno type="wicri:Area/Istex/Corpus">000052</idno>
<idno type="wicri:explorRef" wicri:stream="Istex" wicri:step="Corpus" wicri:corpus="ISTEX">000052</idno>
<idno type="wicri:Area/Istex/Curation">000052</idno>
<idno type="wicri:Area/Istex/Checkpoint">001462</idno>
<idno type="wicri:explorRef" wicri:stream="Istex" wicri:step="Checkpoint">001462</idno>
<idno type="wicri:doubleKey">0300-8584:1980:Heijtink R:influenza:vaccination:in</idno>
<idno type="wicri:Area/Main/Merge">002995</idno>
<idno type="wicri:Area/Main/Curation">002848</idno>
<idno type="wicri:Area/Main/Exploration">002848</idno>
</publicationStmt>
<sourceDesc>
<biblStruct>
<analytic>
<title level="a" type="main" xml:lang="en">Influenza vaccination in HBsAg positive chronic active hepatitis patients treated with interferon</title>
<author>
<name sortKey="Heijtink, R A" sort="Heijtink, R A" uniqKey="Heijtink R" first="R. A." last="Heijtink">R. A. Heijtink</name>
<affiliation wicri:level="1">
<country xml:lang="fr">Pays-Bas</country>
<wicri:regionArea>Department of Virology, Erasmus University Rotterdam, P.O. Box 1738, 3000, DR Rotterdam</wicri:regionArea>
<wicri:noRegion>DR Rotterdam</wicri:noRegion>
</affiliation>
</author>
<author>
<name sortKey="Masurel, N" sort="Masurel, N" uniqKey="Masurel N" first="N." last="Masurel">N. Masurel</name>
<affiliation wicri:level="1">
<country xml:lang="fr">Pays-Bas</country>
<wicri:regionArea>Department of Virology, Erasmus University Rotterdam, P.O. Box 1738, 3000, DR Rotterdam</wicri:regionArea>
<wicri:noRegion>DR Rotterdam</wicri:noRegion>
</affiliation>
</author>
<author>
<name sortKey="Weimar, W" sort="Weimar, W" uniqKey="Weimar W" first="W." last="Weimar">W. Weimar</name>
<affiliation wicri:level="1">
<country xml:lang="fr">Pays-Bas</country>
<wicri:regionArea>Department of Internal Medicine, Erasmus University Rotterdam</wicri:regionArea>
<wicri:noRegion>Erasmus University Rotterdam</wicri:noRegion>
</affiliation>
</author>
<author>
<name sortKey="Schalm, S W" sort="Schalm, S W" uniqKey="Schalm S" first="S. W." last="Schalm">S. W. Schalm</name>
<affiliation wicri:level="1">
<country xml:lang="fr">Pays-Bas</country>
<wicri:regionArea>Department of Internal Medicine, Erasmus University Rotterdam</wicri:regionArea>
<wicri:noRegion>Erasmus University Rotterdam</wicri:noRegion>
</affiliation>
</author>
</analytic>
<monogr></monogr>
<series>
<title level="j">Medical Microbiology and Immunology</title>
<title level="j" type="abbrev">Med Microbiol Immunol</title>
<idno type="ISSN">0300-8584</idno>
<idno type="eISSN">1432-1831</idno>
<imprint>
<publisher>Springer-Verlag</publisher>
<pubPlace>Berlin/Heidelberg</pubPlace>
<date type="published" when="1980-12-01">1980-12-01</date>
<biblScope unit="volume">169</biblScope>
<biblScope unit="issue">1</biblScope>
<biblScope unit="page" from="31">31</biblScope>
<biblScope unit="page" to="38">38</biblScope>
</imprint>
<idno type="ISSN">0300-8584</idno>
</series>
</biblStruct>
</sourceDesc>
<seriesStmt>
<idno type="ISSN">0300-8584</idno>
</seriesStmt>
</fileDesc>
<profileDesc>
<textClass>
<keywords scheme="Teeft" xml:lang="en">
<term>Antibody response</term>
<term>Antibody titer</term>
<term>Antibody titers</term>
<term>Antigenic relationship</term>
<term>Chronic hepatitis</term>
<term>Equine</term>
<term>Equine influenza</term>
<term>Equine virus</term>
<term>Erasmus university rotterdam</term>
<term>Hbsag</term>
<term>Heijtink</term>
<term>Hemagglutination inhibition tests</term>
<term>Hepatitis</term>
<term>Hepatitis patients</term>
<term>Heqlneql</term>
<term>Heqlneql strain</term>
<term>Heqlneql virus</term>
<term>Heterologous elevations</term>
<term>Hswln1</term>
<term>Hswln1 antibodies</term>
<term>Immune</term>
<term>Immune response</term>
<term>Influenza</term>
<term>Influenza antibodies</term>
<term>Influenza strains</term>
<term>Influenza vaccination</term>
<term>Influenza virus</term>
<term>Interferon</term>
<term>Interferon treatment</term>
<term>Leucocyte interferon</term>
<term>Masurel</term>
<term>Mulder</term>
<term>Other influenza</term>
<term>Other influenza strains</term>
<term>Placebo</term>
<term>Placebo group</term>
<term>Placebo groups</term>
<term>Prevaccination</term>
<term>Prevaccination sera</term>
<term>Prevaccination titers</term>
<term>Significant difference</term>
<term>Significant differences</term>
<term>Strains hswln1</term>
<term>Swine influenza virus</term>
<term>Titer</term>
<term>Untreated patients</term>
<term>Vaccination</term>
<term>Vaccine virus</term>
<term>Winter season</term>
</keywords>
</textClass>
<langUsage>
<language ident="en">en</language>
</langUsage>
</profileDesc>
</teiHeader>
<front>
<div type="abstract" xml:lang="en">Abstract: Sixteen patients with hepatitis B antigen (HBsAg) positive chronic active hepatitis (CAH) were vaccinated with the nonhuman influenza A virus Heq1Neq1; eight patients were also treated with leucocyte interferon. Prevaccination sera were negative for specific antibody in hemagglutination inhibition tests. Four weeks after vaccination all patients had responded with a homologous antibody titer. Between the interferon-treated and the untreated groups the differences in antibody titers against the vaccine virus were not significant. Concomitant with the antibody response against the nonhuman influenza virus, a fourfold or higher antibody rise was observed against the influenza A virus strains Hsw1N1 (in six treated and seven untreated patients), H1N1 (in six treated and four untreated patients) and H3N2 (in five treated patients only). The results suggest that a normal specific antibody response in HBsAg positive chronic active hepatitis patients is not significantly altered by leucocyte interferon, and that non-specific antibody production can occur in the absence of a serologic relationship.</div>
</front>
</TEI>
<affiliations>
<list>
<country>
<li>Pays-Bas</li>
</country>
</list>
<tree>
<country name="Pays-Bas">
<noRegion>
<name sortKey="Heijtink, R A" sort="Heijtink, R A" uniqKey="Heijtink R" first="R. A." last="Heijtink">R. A. Heijtink</name>
</noRegion>
<name sortKey="Masurel, N" sort="Masurel, N" uniqKey="Masurel N" first="N." last="Masurel">N. Masurel</name>
<name sortKey="Schalm, S W" sort="Schalm, S W" uniqKey="Schalm S" first="S. W." last="Schalm">S. W. Schalm</name>
<name sortKey="Weimar, W" sort="Weimar, W" uniqKey="Weimar W" first="W." last="Weimar">W. Weimar</name>
</country>
</tree>
</affiliations>
</record>

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Sante/explor/H2N2V1/Data/Main/Exploration
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 002848 | SxmlIndent | more

Ou

HfdSelect -h $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd -nk 002848 | SxmlIndent | more

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Sante
   |area=    H2N2V1
   |flux=    Main
   |étape=   Exploration
   |type=    RBID
   |clé=     ISTEX:B99FB5277EB7FD3526C589F030844890AD4FA601
   |texte=   Influenza vaccination in HBsAg positive chronic active hepatitis patients treated with interferon
}}

Wicri

This area was generated with Dilib version V0.6.33.
Data generation: Tue Apr 14 19:59:40 2020. Site generation: Thu Mar 25 15:38:26 2021